Anna Ou

Anna Ou

Auto-generated profile, based on publicly available information

Anna Ou

Department of Psychiatry, University of California San Diego, La Jolla, CA, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2024 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
AOAnna H Ou
Anna H Ou
SRSara B Rosenthal
Sara B Rosenthal
MAMazda Adli
Mazda Adli
KAKazufumi Akiyama
Kazufumi Akiyama
NANirmala Akula
Nirmala Akula
JKJohn R Kelsoe
John R Kelsoe
Lithium is the gold standard treatment for bipolar disorder (BD). However, its mechanism of action is incompletely understood, and prediction of treatment outcomes is limited. In our previous multi-omics study of the Pharmacogenomics of Bipolar Disorder (PGBD) sample combining transcriptomic and genomic data, we found that focal adhesion, the extracellular matrix (ECM), and PI3K-Akt signaling networks were associated with response to lithium. In this study, we replicated the results of our previous study using network propagation methods in a genome-wide association study of an independent sample of 2039 patients from the International Consortium on Lithium Genetics (ConLiGen) study. We identified functional enrichment in focal adhesion and PI3K-Akt pathways, but we did not find an association with the ECM pathway. Our results suggest that deficits in the neuronal growth cone and PI3K-Akt signaling, but not in ECM proteins, may influence response to lithium in BD.

3 October 2023 in Research Square
Verified
Preprint
Open access
PDF file
JKJohn Kelsoe
John Kelsoe
AOAnna Ou
Anna Ou
SRSara Rosenthal
Sara Rosenthal
MAMazda Adli
Mazda Adli
KAKazufumi Akiyama
Kazufumi Akiyama
MZMaria Del Zompo
Maria Del Zompo
Lithium is the gold standard treatment for bipolar disorder (BD). However, its mechanism of action is incompletely understood, and prediction of treatment outcomes is limited. In our previous multi-omics study of the Pharmacogenomics of Bipolar Disorder (PGBD) sample combining transcriptomic and genomic data, we found that focal adhesion, the extracellular matrix (ECM), and PI3K-Akt signaling networks were associated with response to lithium. In this study, we replicated the results of our previous study using network propagation methods in a genome-wide association study of an independent sample of 2,039 patients from the International Consortium on Lithium Genetics (ConLiGen) study. We identified functional enrichment in focal adhesion and PI3K-Akt pathways, but we did not find an association with the ECM pathway. Our results suggest that deficits in the neuronal growth cone and PI3K-Akt signaling, but not in ECM proteins, may influence response to lithium in BD.